Aktie 4114 SYNMOSA BIOPHARMA CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Synmosa Biopharma Corporation

Aktien

4114

TW0004114004

4114

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 10.05.2024 		% 5 Tage % 1. Jan.
39,55 TWD +1,15 % Intraday Chart für Synmosa Biopharma Corporation +2,06 % +2,33 %
29.03. Synmosa Biopharma Corporation berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
16.01. Synmosa Biopharma Corporation kündigt Änderungen in der fünften Sitzung des Vergütungsausschusses an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Member of the Audit Committee
Synmosa Biopharma Corporation announced that it expects to receive TWD 950 million in funding
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022
Synmosa Biopharma Corporation Announces Changes of Corporate Governance Officer
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Synmosa Biopharma : The Company is invited to attend institutional investor conference held by IBF Securities
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4114 Aktie
  4. Nachrichten Synmosa Biopharma Corporation
  5. Andere Sprachen